One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory
doi : 10.1016/j.jchf.2026.103180
Volume 14, Issue 8, August 2026, 103180
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE
doi : 10.1016/j.jchf.2026.102999
Volume 14, Issue 8, August 2026, 102999
Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial
doi : 10.1016/j.jchf.2026.103062
Volume 14, Issue 8, August 2026, 103062
From Loop Diuretics to Closed-Loop Decongestion: Are We Ready for Algorithm-Guided Heart Failure Care?
doi : 10.1016/j.jchf.2026.103067
Volume 14, Issue 8, August 2026, 103067
Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and Obesity
doi : 10.1016/j.jchf.2026.103060
Volume 14, Issue 8, August 2026, 103060
Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy
doi : 10.1016/j.jchf.2026.103149
Volume 14, Issue 8, August 2026, 103149
Hypertrophic Cardiomyopathy in the Genomic Era: Genetic Testing Is No Longer Optional
doi : 10.1016/j.jchf.2026.103177
Volume 14, Issue 8, August 2026, 103177
10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients
doi : 10.1016/j.jchf.2026.103115
Volume 14, Issue 8, August 2026, 103115
The MagMa Study: Quantum Magnetocardiography in Cardiomyopathy
doi : 10.1016/j.jchf.2026.103182
Volume 14, Issue 8, August 2026, 103182
Refining the Definition for “Low Risk” in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality
doi : 10.1016/j.jchf.2026.103151
Volume 14, Issue 8, August 2026, 103151
REVEALing New Standards: Low Risk Redefined
doi : 10.1016/j.jchf.2026.103189
Volume 14, Issue 8, August 2026, 103189
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced Trial
doi : 10.1016/j.jchf.2026.103166
Volume 14, Issue 8, August 2026, 103166
When the Exception Becomes the Rule: Rethinking Exception Letters in Heart Transplant Allocation
doi : 10.1016/j.jchf.2026.103102
Volume 14, Issue 8, August 2026, 103102
Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium Exposure
doi : 10.1016/j.jchf.2026.103114
Volume 14, Issue 8, August 2026, 103114
Dapagliflozin in Patients With Heart Failure Across the Care Spectrum: A Meta-Analysis of DAPA-HF, DELIVER, and DAPA ACT HF-TIMI 68
doi : 10.1016/j.jchf.2026.103232
Volume 14, Issue 8, August 2026, 103232
Multidimensional Patient-Reported Outcomes in Acutely Decompensated Heart Failure: Prognostic Implications in a Real-World Cohort
doi : 10.1016/j.jchf.2026.103050
Volume 14, Issue 8, August 2026, 103050
Fetal Right Ventricular Dilatation and Dysfunction as a Precursor of Dilated Cardiomyopathy: A Diagnostic Pitfall and a Call for Vigilance
doi : 10.1016/j.jchf.2026.103048
Volume 14, Issue 8, August 2026, 103048
When the Right Ventricle Speaks First: Fetal Clues to Future Left-Sided Dilated Cardiomyopathy
doi : 10.1016/j.jchf.2026.103148
Volume 14, Issue 8, August 2026, 103148
Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk
doi : 10.1016/j.jchf.2026.103057
Volume 14, Issue 8, August 2026, 103057
Clinical Characteristics and Outcomes of Takotsubo Syndrome With Left Ventricular Outflow Tract Obstruction
doi : 10.1016/j.jchf.2026.103059
Volume 14, Issue 8, August 2026, 103059
Aortic Pulsatility Index and Native Heart Survival in Patients With Heart Failure–Related Cardiogenic Shock
doi : 10.1016/j.jchf.2026.103058
Volume 14, Issue 8, August 2026, 103058
Impact of Transcatheter Tricuspid Valve Replacement on Liver and Kidney Function in a Real-World Population
doi : 10.1016/j.jchf.2026.103069
Volume 14, Issue 8, August 2026, 103069
Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National Survey
doi : 10.1016/j.jchf.2026.103065
Volume 14, Issue 8, August 2026, 103065
Contemporary Trends in Heart Failure Mortality: The Pandemic Ended, the Epidemic Continues
doi : 10.1016/j.jchf.2026.103066
Volume 14, Issue 8, August 2026, 103066
Forty Years of Heart Failure Drug Clinical Trials: Have We Made Progress on Enrollment?
doi : 10.1016/j.jchf.2026.103068
Volume 14, Issue 8, August 2026, 103068
Istaroxime’s Effect on Hemodynamics and Arrhythmias in Cardiogenic Shock: A Pooled Analysis of SEISMiC Trials
doi : 10.1016/j.jchf.2026.103103
Volume 14, Issue 8, August 2026, 103103
Reappraisal of Renal Sodium Handling in the FASTR Trial
doi : 10.1016/j.jchf.2026.103231
Volume 14, Issue 8, August 2026, 103231
Reply: Reappraisal of Renal Sodium Handling in the FASTR Trial
doi : 10.1016/j.jchf.2026.103230
Volume 14, Issue 8, August 2026, 103230
Angiotensin Receptor-Neprilysin Inhibitors for Kidney Protection in Heart Failure and Chronic Kidney Disease: Is There Still a Place?
doi : 10.1016/j.jchf.2026.103169
Volume 14, Issue 8, August 2026, 103169
REPLY: Angiotensin Receptor-Neprilysin Inhibitors for Kidney Protection in Heart Failure and Chronic Kidney Disease: Is There Still a Place?
doi : 10.1016/j.jchf.2026.103170
Volume 14, Issue 8, August 2026, 103170
